speb/financial-data huggingface dataset:
CTRM balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 20628512.00
CTRM income_statement (annual, 2025-12-31) — General And Administrative Expense: 19429796.00
CTRM income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 5302740.00
CTRM balance_sheet (annual, 2025-12-31) — Goodwill: 24126824.00
CTRM balance_sheet (quarterly, 2025-12-31) — Goodwill: 24126824.00
CTRM balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 45300227.00
CTRM balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 45300227.00
CTRM balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 7909514.00
CTRM balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 7909514.00
CTRM balance_sheet (annual, 2025-12-31) — Gross PPE: 229726456.00
CTRM balance_sheet (quarterly, 2025-12-31) — Gross PPE: 229726456.00
CTRM income_statement (annual, 2025-12-31) — Gross Profit: 21718294.00
CTRM income_statement (quarterly, 2025-12-31) — Gross Profit: 5858615.00
CTRM balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 545630.00
CTRM balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 545630.00
CTRM balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 750000.00
CTRM balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 750000.00
CTRM cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 7152131.00
CTRM balance_sheet (annual, 2025-12-31) — Income Tax Payable: 3482684.00
CTRM balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 3482684.00
CTRM income_statement (annual, 2025-12-31) — Interest Expense: 3041414.00
CTRM income_statement (quarterly, 2025-12-31) — Interest Expense: 484133.00
CTRM income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 3041414.00
CTRM income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 484133.00
CTRM income_statement (annual, 2025-12-31) — Interest Income: 1912530.00
CTRM income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1912530.00
CTRM cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 3132785.00
CTRM balance_sheet (annual, 2025-12-31) — Inventory: 791788.00
CTRM balance_sheet (quarterly, 2025-12-31) — Inventory: 791788.00
CTRM balance_sheet (annual, 2025-12-31) — Invested Capital: 596060912.00
CTRM balance_sheet (quarterly, 2025-12-31) — Invested Capital: 596060912.00
CTRM cash_flow (annual, 2025-12-31) — Investing Cash Flow: 97066285.00
CTRM cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 29086223.00
CTRM balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 10682222.00
CTRM balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 10682222.00
CTRM balance_sheet (annual, 2025-12-31) — Investments And Advances: 317995558.00
CTRM balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 317995558.00
CTRM balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 307313336.00
CTRM balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 307313336.00
CTRM cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 60000000.00
CTRM cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CTRM cash_flow (annual, 2025-12-31) — Issuance Of Debt: 51577002.00
CTRM cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 50000000.00
CTRM balance_sheet (annual, 2025-12-31) — Leases: 2228502.00
CTRM balance_sheet (quarterly, 2025-12-31) — Leases: 2228502.00
CTRM balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 6213857.00
CTRM balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 6213857.00
CTRM balance_sheet (annual, 2025-12-31) — Long Term Debt: 64992597.00
CTRM balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 64992597.00
CTRM balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 71206454.00
CTRM balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 71206454.00
CTRM cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 51577002.00
CTRM cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 50000000.00
CTRM cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -102181653.00
CTRM cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -563453.00
CTRM balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 307313336.00
CTRM balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 307313336.00
CTRM balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 248982.00
CTRM balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 248982.00
CTRM balance_sheet (annual, 2025-12-31) — Minority Interest: 62812696.00
CTRM balance_sheet (quarterly, 2025-12-31) — Minority Interest: 62812696.00
CTRM income_statement (annual, 2025-12-31) — Minority Interests: -2273340.00
CTRM income_statement (quarterly, 2025-12-31) — Minority Interests: -3470079.00
CTRM cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -21866248.00
CTRM cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -755128.00
CTRM cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 733372.00
CTRM cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 734489.00
CTRM income_statement (annual, 2025-12-31) — Net Income: 19268823.00
CTRM income_statement (quarterly, 2025-12-31) — Net Income: 14084788.00
CTRM income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 10925627.00
CTRM income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 11684119.00
CTRM income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 21542163.00
CTRM income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 17554867.00
CTRM income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
CTRM income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 19268823.00
CTRM income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 14084788.00
CTRM income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 19268823.00
CTRM income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 14084788.00
CTRM cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 21542163.00
CTRM cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 17554867.00
CTRM income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 21542163.00
CTRM income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 17554867.00
CTRM income_statement (annual, 2025-12-31) — Net Interest Income: -3059198.00
CTRM income_statement (quarterly, 2025-12-31) — Net Interest Income: -501917.00
CTRM cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 57472626.00
CTRM cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 30367434.00
CTRM cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -50604651.00
CTRM cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 49436547.00
CTRM cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -50604651.00
CTRM cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 49436547.00
CTRM income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -3059198.00
CTRM income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -501917.00
CTRM cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 9199204.00
CTRM cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1621472.00
CTRM cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 413043.00
CTRM cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -353085.00
CTRM balance_sheet (annual, 2025-12-31) — Net PPE: 198572178.00
CTRM balance_sheet (quarterly, 2025-12-31) — Net PPE: 198572178.00
CTRM cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 61046864.00
CTRM cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -172998.00
CTRM cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
CTRM cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: -60000000.00
CTRM balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 560844555.00
CTRM balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 560844555.00
CTRM balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 2893839.00
CTRM balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 2893839.00
CTRM balance_sheet (annual, 2025-12-31) — Non Current Accrued Expenses: 144605.00
CTRM balance_sheet (quarterly, 2025-12-31) — Non Current Accrued Expenses: 144605.00
CTRM balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 8665781.00
CTRM balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 8665781.00
CTRM balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 10596230.00
CTRM balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 10596230.00
CTRM balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 2599327.00
CTRM balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 2599327.00
CTRM balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 10596230.00
CTRM balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 10596230.00
CTRM income_statement (annual, 2025-12-31) — Normalized EBITDA: 8260666.00
CTRM income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -1250347.00
CTRM income_statement (annual, 2025-12-31) — Normalized Income: -10469182.40
CTRM income_statement (quarterly, 2025-12-31) — Normalized Income: -9689977.69
CTRM cash_flow (annual, 2025-12-31) — Operating Cash Flow: 10046351.00
CTRM cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 12464037.00
CTRM cash_flow (annual, 2025-12-31) — Operating Gains Losses: 8880578.00
CTRM cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -10954912.00
CTRM income_statement (annual, 2025-12-31) — Operating Income: -92883.00
CTRM income_statement (quarterly, 2025-12-31) — Operating Income: 1350965.00
CTRM income_statement (annual, 2025-12-31) — Operating Revenue: 81814405.00
CTRM income_statement (quarterly, 2025-12-31) — Operating Revenue: 22565392.00
CTRM balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 9662354.00
CTRM balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 9662354.00
CTRM balance_sheet (annual, 2025-12-31) — Other Current Assets: 3407988.00
CTRM balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 3407988.00
CTRM balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 5637620.00
CTRM balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 5637620.00
CTRM balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1734317.00
CTRM balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1734317.00
CTRM balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 20628512.00
CTRM balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 20628512.00
CTRM income_statement (annual, 2025-12-31) — Other Gand A: 14477183.00
CTRM income_statement (quarterly, 2025-12-31) — Other Gand A: 350127.00
CTRM income_statement (annual, 2025-12-31) — Other Income Expense: 25560113.00
CTRM income_statement (quarterly, 2025-12-31) — Other Income Expense: 17426775.00
CTRM balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 21173403.00
CTRM balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 21173403.00
CTRM cash_flow (annual, 2025-12-31) — Other Non Cash Items: -4668500.00
CTRM cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -417115.00
CTRM balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1805182.00
CTRM balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1805182.00
CTRM balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 12046770.00
CTRM balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 12046770.00
CTRM income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 4692704.00
CTRM income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -17640184.00
CTRM income_statement (annual, 2025-12-31) — Other Operating Expenses: 4022007.00
CTRM income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 866932.00
CTRM balance_sheet (annual, 2025-12-31) — Other Properties: 41166281.00
CTRM balance_sheet (quarterly, 2025-12-31) — Other Properties: 41166281.00
CTRM balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 28314699.00
CTRM balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 28314699.00
CTRM income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CTRM balance_sheet (annual, 2025-12-31) — Payables: 8303988.00
CTRM balance_sheet (quarterly, 2025-12-31) — Payables: 8303988.00
CTRM balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 25003988.00
CTRM balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 25003988.00
CTRM balance_sheet (annual, 2025-12-31) — Preferred Stock: 80714087.00
CTRM balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 80714087.00
CTRM cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -4910934.00
CTRM cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -1563712.00
CTRM income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 8343196.00
CTRM income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 2400669.00
CTRM balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 80714087.00
CTRM balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 80714087.00
CTRM cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 60000000.00
CTRM cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 0.00
CTRM cash_flow (annual, 2025-12-31) — Preferred Stock Payments: -60000000.00
CTRM income_statement (annual, 2025-12-31) — Pretax Income: 22408032.00
CTRM income_statement (quarterly, 2025-12-31) — Pretax Income: 18275823.00
CTRM cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CTRM cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CTRM income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: -1640626.00
CTRM income_statement (quarterly, 2025-12-31) — Provision For Doubtful Accounts: -1662022.00
CTRM cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -1640626.00
CTRM cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: -1662022.00
CTRM cash_flow (annual, 2025-12-31) — Purchase Of Business: -26935397.00
CTRM cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -755128.00
CTRM cash_flow (annual, 2025-12-31) — Purchase Of Investment: -17490927.00
CTRM cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -3299067.00
CTRM cash_flow (annual, 2025-12-31) — Purchase Of PPE: -889260.00
CTRM cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -172998.00
CTRM balance_sheet (annual, 2025-12-31) — Receivables: 36579640.00
CTRM balance_sheet (quarterly, 2025-12-31) — Receivables: 36579640.00
CTRM income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 60096111.00
CTRM income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 16706777.00
CTRM income_statement (annual, 2025-12-31) — Reconciled Depreciation: 14760087.00
CTRM income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 4740862.00
CTRM income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 1808558.00
CTRM cash_flow (annual, 2025-12-31) — Repayment Of Debt: -102181653.00
CTRM cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -563453.00
CTRM cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -60000000.00
CTRM income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CTRM balance_sheet (annual, 2025-12-31) — Retained Earnings: 239452780.00
CTRM balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 239452780.00
CTRM income_statement (annual, 2025-12-31) — Salaries And Wages: 4952613.00
CTRM cash_flow (annual, 2025-12-31) — Sale Of Business: 5069149.00
CTRM cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
CTRM cash_flow (annual, 2025-12-31) — Sale Of Investment: 74963553.00
CTRM cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 33666501.00
CTRM cash_flow (annual, 2025-12-31) — Sale Of PPE: 61936124.00
CTRM cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
CTRM income_statement (annual, 2025-12-31) — Selling General And Administration: 19429796.00
CTRM income_statement (quarterly, 2025-12-31) — Selling General And Administration: 5302740.00
CTRM balance_sheet (annual, 2025-12-31) — Share Issued: 9662354.00
CTRM balance_sheet (quarterly, 2025-12-31) — Share Issued: 9662354.00
CTRM income_statement (annual, 2025-12-31) — Special Income Charges: -7250417.00
CTRM income_statement (quarterly, 2025-12-31) — Special Income Charges: -100014.00
CTRM cash_flow (annual, 2025-12-31) — Stock Based Compensation: 515351.00
CTRM cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 61723.00
CTRM balance_sheet (annual, 2025-12-31) — Stockholders Equity: 606144782.00
CTRM balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 606144782.00
CTRM balance_sheet (annual, 2025-12-31) — Tangible Book Value: 480130468.00
CTRM balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 480130468.00
CTRM income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 2210861.60
CTRM income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 976399.31
CTRM income_statement (annual, 2025-12-31) — Tax Provision: 865869.00
CTRM income_statement (quarterly, 2025-12-31) — Tax Provision: 720956.00
CTRM income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.07
CTRM income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.04
CTRM balance_sheet (annual, 2025-12-31) — Taxes Receivable: 15514617.00
CTRM balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 15514617.00
CTRM balance_sheet (annual, 2025-12-31) — Total Assets: 797358441.00
CTRM balance_sheet (quarterly, 2025-12-31) — Total Assets: 797358441.00
CTRM balance_sheet (annual, 2025-12-31) — Total Capitalization: 671137379.00
CTRM balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 671137379.00
CTRM balance_sheet (annual, 2025-12-31) — Total Debt: 78047843.00
CTRM balance_sheet (quarterly, 2025-12-31) — Total Debt: 78047843.00
CTRM balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 668957478.00
CTRM balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 668957478.00
CTRM income_statement (annual, 2025-12-31) — Total Expenses: 81907288.00
CTRM income_statement (quarterly, 2025-12-31) — Total Expenses: 21214427.00
CTRM balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 128400963.00
CTRM balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 128400963.00
CTRM balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 575943567.00
CTRM balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 575943567.00
CTRM balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 93994059.00
CTRM balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 93994059.00
CTRM income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -18424758.00
CTRM income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 11566745.00
CTRM income_statement (annual, 2025-12-31) — Total Other Finance Cost: 1930314.00
CTRM balance_sheet (annual, 2025-12-31) — Total Tax Payable: 3482684.00
CTRM balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 3482684.00
CTRM income_statement (annual, 2025-12-31) — Total Unusual Items: 31948867.00
CTRM income_statement (quarterly, 2025-12-31) — Total Unusual Items: 24751165.00
CTRM income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 31948867.00
CTRM income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 24751165.00
CTRM cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -24728740.00
CTRM cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -3064843.00
CTRM balance_sheet (annual, 2025-12-31) — Working Capital: 187007970.00
CTRM balance_sheet (quarterly, 2025-12-31) — Working Capital: 187007970.00
CTRM income_statement (quarterly, 2026-03-31) — +Operating Expense: 4670874.00
CTRM income_statement (quarterly, 2026-03-31) — +Total Revenue: 21257942.00
CTRM balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 265339741.00
CTRM income_statement (quarterly, 2026-03-31) — Basic Average Shares: 9662354.00
CTRM income_statement (quarterly, 2026-03-31) — Basic EPS: 4.65
CTRM cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 152775129.00
CTRM cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -115986.00
CTRM balance_sheet (quarterly, 2026-03-31) — Capital Stock: 81523565.00
CTRM balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 191809759.00
CTRM balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 211702776.00
CTRM cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -1250000.00
CTRM cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 11600614.00
CTRM cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 20934456.00
CTRM cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 8609260.00
CTRM cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -446428.00
CTRM cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -865023.00
CTRM cash_flow (quarterly, 2026-03-31) — Change In Inventory: -19705.00
CTRM cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 2637953.00
CTRM cash_flow (quarterly, 2026-03-31) — Change In Payable: -446428.00
CTRM cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -1311451.00
CTRM cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -287561.00
CTRM cash_flow (quarterly, 2026-03-31) — Change In Receivables: 10823.00
CTRM cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 1030059.00
CTRM cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 10823.00
CTRM cash_flow (quarterly, 2026-03-31) — Changes In Cash: 41144330.00
CTRM balance_sheet (quarterly, 2026-03-31) — Common Stock: 9662.00
CTRM balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 565380227.00
CTRM income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 14338090.00
CTRM balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 15731739.00
CTRM balance_sheet (quarterly, 2026-03-31) — Current Assets: 250900265.00
CTRM balance_sheet (quarterly, 2026-03-31) — Current Debt: 6479332.00
CTRM balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 6479332.00
CTRM balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 36484936.00
CTRM cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 1582716.00
CTRM cash_flow (quarterly, 2026-03-31) — Deferred Tax: 1582716.00
CTRM cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3696879.00
CTRM cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3696879.00
CTRM income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 56558376.00
CTRM income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.83
CTRM income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 44945901.00
CTRM cash_flow (quarterly, 2026-03-31) — Dividend Received Cfo: 4205117.00
CTRM balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 10828910.00
CTRM balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Non Current: 2893839.00
CTRM balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 1073082.00
CTRM income_statement (quarterly, 2026-03-31) — EBIT: 2248978.00
CTRM income_statement (quarterly, 2026-03-31) — EBITDA: 5945857.00
CTRM income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 46138327.00
CTRM cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -46138327.00
CTRM cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -1109700.00
CTRM cash_flow (quarterly, 2026-03-31) — End Cash Position: 192809759.00
CTRM cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 11600614.00
CTRM cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 8493274.00
CTRM cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -7686197.00
CTRM cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
CTRM income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 637.00
CTRM income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 4205117.00
CTRM balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 15632143.00
CTRM income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 3899356.00
CTRM balance_sheet (quarterly, 2026-03-31) — Goodwill: 23551297.00
CTRM balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 43663514.00
CTRM balance_sheet (quarterly, 2026-03-31) — Gross PPE: 187835922.00
CTRM income_statement (quarterly, 2026-03-31) — Gross Profit: 6919852.00
CTRM balance_sheet (quarterly, 2026-03-31) — Invested Capital: 634099791.00
CTRM cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 20934456.00
CTRM balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 376306557.00
CTRM balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 376306557.00
CTRM cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
CTRM balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 62240232.00
CTRM balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 62240232.00
CTRM cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
CTRM cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1511693.00
CTRM balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 376306557.00
CTRM balance_sheet (quarterly, 2026-03-31) — Minority Interest: 104681071.00
CTRM income_statement (quarterly, 2026-03-31) — Minority Interests: -22222104.00
CTRM cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 5846526.00
CTRM cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -11179216.00
CTRM income_statement (quarterly, 2026-03-31) — Net Income: 46995717.00
CTRM income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 44945901.00
CTRM income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 69217821.00
CTRM income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 46995717.00
CTRM income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 46995717.00
CTRM cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 69217821.00
CTRM income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 69217821.00
CTRM income_statement (quarterly, 2026-03-31) — Net Interest Income: -337528.00
CTRM cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 15203916.00
CTRM cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1511693.00
CTRM cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1511693.00
CTRM income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -337528.00
CTRM cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 14362307.00
CTRM balance_sheet (quarterly, 2026-03-31) — Net PPE: 187835922.00
CTRM cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -115986.00
CTRM balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 603230616.00
CTRM balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 2893839.00
CTRM balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 11624337.00
CTRM balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 11624337.00
CTRM income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1740103.00
CTRM income_statement (quarterly, 2026-03-31) — Normalized Income: 42883772.06
CTRM cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 8609260.00
CTRM cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -65004377.00
CTRM income_statement (quarterly, 2026-03-31) — Operating Income: 2248978.00
CTRM income_statement (quarterly, 2026-03-31) — Operating Revenue: 21257942.00
CTRM balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 9662354.00
CTRM balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 28368579.00
CTRM balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 6479332.00
CTRM balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 13200783.00
CTRM balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 15632143.00
CTRM income_statement (quarterly, 2026-03-31) — Other Gand A: 3899356.00
CTRM income_statement (quarterly, 2026-03-31) — Other Income Expense: 68885492.00
CTRM balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 20112217.00
CTRM cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -2832217.00
CTRM balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 31443636.00
CTRM balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 31119027.00
CTRM income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 18541411.00
CTRM income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 847140.00
CTRM balance_sheet (quarterly, 2026-03-31) — Other Properties: 33576594.00
CTRM balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 19893017.00
CTRM balance_sheet (quarterly, 2026-03-31) — Payables: 1073082.00
CTRM balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 16804821.00
CTRM balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 81513903.00
CTRM cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -1250000.00
CTRM income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 2049816.00
CTRM balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 81513903.00
CTRM income_statement (quarterly, 2026-03-31) — Pretax Income: 70796942.00
CTRM income_statement (quarterly, 2026-03-31) — Provision For Doubtful Accounts: -75622.00
CTRM cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: -75622.00
CTRM cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -1143281.00
CTRM cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
CTRM cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -115986.00
CTRM balance_sheet (quarterly, 2026-03-31) — Receivables: 10828910.00
CTRM income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 14338090.00
CTRM income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3696879.00
CTRM cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1511693.00
CTRM balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 284398681.00
CTRM cash_flow (quarterly, 2026-03-31) — Sale Of Business: 6989807.00
CTRM cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 15203916.00
CTRM cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
CTRM income_statement (quarterly, 2026-03-31) — Selling General And Administration: 3899356.00
CTRM balance_sheet (quarterly, 2026-03-31) — Share Issued: 9662354.00
CTRM income_statement (quarterly, 2026-03-31) — Special Income Charges: 637.00
CTRM cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 62575.00
CTRM balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 646894130.00
CTRM balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 521716713.00
CTRM income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 93809.06
CTRM income_statement (quarterly, 2026-03-31) — Tax Provision: 1579121.00
CTRM income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.02
CTRM balance_sheet (quarterly, 2026-03-31) — Total Assets: 893043733.00
CTRM balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 709134362.00
CTRM balance_sheet (quarterly, 2026-03-31) — Total Debt: 68719564.00
CTRM balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 751575201.00
CTRM income_statement (quarterly, 2026-03-31) — Total Expenses: 19008964.00
CTRM balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 141468532.00
CTRM balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 642143468.00
CTRM balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 104983596.00
CTRM income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 48387942.00
CTRM income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 337528.00
CTRM income_statement (quarterly, 2026-03-31) — Total Unusual Items: 4205754.00
CTRM income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 4205754.00
CTRM cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: -3273691.00
CTRM balance_sheet (quarterly, 2026-03-31) — Working Capital: 214415329.00
CTRN cash_flow (annual, 2022-01-31) — Cash Dividends Paid: 0.00
CTRN cash_flow (annual, 2022-01-31) — Common Stock Dividend Paid: 0.00
CTRN cash_flow (annual, 2022-01-31) — Income Tax Paid Supplemental Data: 22409000.00
CTRN balance_sheet (annual, 2022-01-31) — Income Tax Payable: 0.00
CTRN cash_flow (annual, 2022-01-31) — Issuance Of Debt: 0.00
CTRN balance_sheet (annual, 2022-01-31) — Land And Improvements: 479000.00
CTRN cash_flow (annual, 2022-01-31) — Net Investment Purchase And Sale: 0.00
CTRN cash_flow (annual, 2022-01-31) — Net Issuance Payments Of Debt: 0.00
CTRN cash_flow (annual, 2022-01-31) — Net Other Investing Changes: 192000.00
CTRN cash_flow (annual, 2022-01-31) — Net Short Term Debt Issuance: 0.00
CTRN balance_sheet (annual, 2022-01-31) — Non Current Deferred Assets: 2992000.00
CTRN balance_sheet (annual, 2022-01-31) — Non Current Deferred Taxes Assets: 2992000.00
CTRN balance_sheet (annual, 2022-01-31) — Other Current Liabilities: 364000.00
CTRN balance_sheet (annual, 2022-01-31) — Prepaid Assets: 14997000.00
CTRN cash_flow (annual, 2022-01-31) — Purchase Of Investment: -35272000.00
CTRN cash_flow (annual, 2022-01-31) — Repayment Of Debt: 0.00
CTRN cash_flow (annual, 2022-01-31) — Sale Of Investment: 35272000.00
CTRN cash_flow (annual, 2022-01-31) — Short Term Debt Issuance: 0.00
CTRN cash_flow (annual, 2022-01-31) — Short Term Debt Payments: 0.00
CTRN balance_sheet (annual, 2022-01-31) — Total Tax Payable: 0.00
CTRN income_statement (annual, 2023-01-31) — +Operating Expense: 299772000.00
CTRN income_statement (annual, 2023-01-31) — +Total Revenue: 795011000.00
CTRN balance_sheet (annual, 2023-01-31) — Accounts Payable: 80670000.00
CTRN balance_sheet (annual, 2023-01-31) — Accumulated Depreciation: -262525000.00
CTRN balance_sheet (annual, 2023-01-31) — Additional Paid In Capital: 102445000.00
CTRN cash_flow (annual, 2023-01-31) — Asset Impairment Charge: 0.00
CTRN income_statement (annual, 2023-01-31) — Basic Average Shares: 8216000.00
CTRN income_statement (annual, 2023-01-31) — Basic EPS: 7.17
CTRN cash_flow (annual, 2023-01-31) — Beginning Cash Position: 49788000.00
CTRN balance_sheet (annual, 2023-01-31) — Buildings And Improvements: 4786000.00
CTRN cash_flow (annual, 2023-01-31) — Capital Expenditure: -22287000.00
CTRN balance_sheet (annual, 2023-01-31) — Capital Lease Obligations: 267600000.00
CTRN balance_sheet (annual, 2023-01-31) — Capital Stock: 160000.00
CTRN balance_sheet (annual, 2023-01-31) — Cash And Cash Equivalents: 103495000.00
CTRN balance_sheet (annual, 2023-01-31) — Cash Cash Equivalents And Short Term Investments: 103495000.00
CTRN cash_flow (annual, 2023-01-31) — Cash Dividends Paid: 0.00
CTRN cash_flow (annual, 2023-01-31) — Cash Flow From Continuing Financing Activities: -12228000.00
CTRN cash_flow (annual, 2023-01-31) — Cash Flow From Continuing Investing Activities: 60181000.00
CTRN cash_flow (annual, 2023-01-31) — Cash Flow From Continuing Operating Activities: 5754000.00
CTRN cash_flow (annual, 2023-01-31) — Change In Account Payable: -18329000.00
CTRN cash_flow (annual, 2023-01-31) — Change In Accrued Expense: -69917000.00
CTRN cash_flow (annual, 2023-01-31) — Change In Inventory: 16826000.00
CTRN cash_flow (annual, 2023-01-31) — Change In Other Current Assets: 134000.00
CTRN cash_flow (annual, 2023-01-31) — Change In Other Working Capital: 3372000.00
CTRN cash_flow (annual, 2023-01-31) — Change In Payable: -18329000.00
CTRN cash_flow (annual, 2023-01-31) — Change In Payables And Accrued Expense: -88246000.00
CTRN cash_flow (annual, 2023-01-31) — Change In Prepaid Assets: 1640000.00
CTRN cash_flow (annual, 2023-01-31) — Change In Working Capital: -66274000.00
CTRN cash_flow (annual, 2023-01-31) — Changes In Cash: 53707000.00
CTRN balance_sheet (annual, 2023-01-31) — Common Stock: 160000.00
CTRN cash_flow (annual, 2023-01-31) — Common Stock Dividend Paid: 0.00
CTRN balance_sheet (annual, 2023-01-31) — Common Stock Equity: 166444000.00
CTRN cash_flow (annual, 2023-01-31) — Common Stock Payments: -10000000.00
CTRN balance_sheet (annual, 2023-01-31) — Construction In Progress: 1402000.00
CTRN income_statement (annual, 2023-01-31) — Cost Of Revenue: 484022000.00
CTRN balance_sheet (annual, 2023-01-31) — Current Accrued Expenses: 16055000.00
CTRN balance_sheet (annual, 2023-01-31) — Current Assets: 222881000.00
CTRN balance_sheet (annual, 2023-01-31) — Current Capital Lease Obligation: 52661000.00
CTRN balance_sheet (annual, 2023-01-31) — Current Debt And Capital Lease Obligation: 52661000.00
CTRN balance_sheet (annual, 2023-01-31) — Current Deferred Liabilities: 344000.00
CTRN balance_sheet (annual, 2023-01-31) — Current Deferred Revenue: 344000.00
CTRN balance_sheet (annual, 2023-01-31) — Current Liabilities: 160553000.00
CTRN cash_flow (annual, 2023-01-31) — Deferred Income Tax: 99000.00
CTRN cash_flow (annual, 2023-01-31) — Deferred Tax: 99000.00
CTRN cash_flow (annual, 2023-01-31) — Depreciation: 20595000.00
CTRN cash_flow (annual, 2023-01-31) — Depreciation Amortization Depletion: 20595000.00
CTRN income_statement (annual, 2023-01-31) — Depreciation Amortization Depletion Income Statement: 20595000.00
CTRN cash_flow (annual, 2023-01-31) — Depreciation And Amortization: 20595000.00
CTRN income_statement (annual, 2023-01-31) — Depreciation And Amortization In Income Statement: 20595000.00
CTRN income_statement (annual, 2023-01-31) — Depreciation Income Statement: 20595000.00
CTRN income_statement (annual, 2023-01-31) — Diluted Average Shares: 8216000.00
CTRN income_statement (annual, 2023-01-31) — Diluted EPS: 7.17
CTRN income_statement (annual, 2023-01-31) — Diluted NI Availto Com Stockholders: 58892000.00
CTRN income_statement (annual, 2023-01-31) — EBIT: 76339000.00
CTRN income_statement (annual, 2023-01-31) — EBITDA: 96934000.00
CTRN cash_flow (annual, 2023-01-31) — End Cash Position: 103495000.00
CTRN cash_flow (annual, 2023-01-31) — Financing Cash Flow: -12228000.00
CTRN cash_flow (annual, 2023-01-31) — Free Cash Flow: -16533000.00
CTRN cash_flow (annual, 2023-01-31) — Gain Loss On Sale Of PPE: -64078000.00
CTRN income_statement (annual, 2023-01-31) — Gain On Sale Of Ppe: 64088000.00
CTRN balance_sheet (annual, 2023-01-31) — Gross PPE: 579826000.00
CTRN income_statement (annual, 2023-01-31) — Gross Profit: 310989000.00
CTRN income_statement (annual, 2023-01-31) — Impairment Of Capital Assets: 0.00
CTRN cash_flow (annual, 2023-01-31) — Income Tax Paid Supplemental Data: 13842000.00
CTRN income_statement (annual, 2023-01-31) — Interest Expense: 306000.00
CTRN income_statement (annual, 2023-01-31) — Interest Expense Non Operating: 306000.00
CTRN income_statement (annual, 2023-01-31) — Interest Income: 1034000.00
CTRN income_statement (annual, 2023-01-31) — Interest Income Non Operating: 1034000.00
CTRN cash_flow (annual, 2023-01-31) — Interest Paid Supplemental Data: 158000.00
CTRN balance_sheet (annual, 2023-01-31) — Inventory: 105794000.00
CTRN balance_sheet (annual, 2023-01-31) — Invested Capital: 166444000.00
CTRN cash_flow (annual, 2023-01-31) — Investing Cash Flow: 60181000.00
CTRN cash_flow (annual, 2023-01-31) — Issuance Of Debt: 0.00
CTRN balance_sheet (annual, 2023-01-31) — Land And Improvements: 0.00
CTRN balance_sheet (annual, 2023-01-31) — Leases: 128522000.00
CTRN balance_sheet (annual, 2023-01-31) — Long Term Capital Lease Obligation: 214939000.00
CTRN balance_sheet (annual, 2023-01-31) — Long Term Debt And Capital Lease Obligation: 214939000.00
CTRN balance_sheet (annual, 2023-01-31) — Machinery Furniture Equipment: 187921000.00
CTRN cash_flow (annual, 2023-01-31) — Net Common Stock Issuance: -10000000.00
CTRN income_statement (annual, 2023-01-31) — Net Income: 58892000.00
CTRN income_statement (annual, 2023-01-31) — Net Income Common Stockholders: 58892000.00
CTRN income_statement (annual, 2023-01-31) — Net Income Continuous Operations: 58892000.00
CTRN income_statement (annual, 2023-01-31) — Net Income From Continuing And Discontinued Operation: 58892000.00
CTRN income_statement (annual, 2023-01-31) — Net Income From Continuing Operation Net Minority Interest: 58892000.00
CTRN cash_flow (annual, 2023-01-31) — Net Income From Continuing Operations: 58892000.00
CTRN income_statement (annual, 2023-01-31) — Net Income Including Noncontrolling Interests: 58892000.00
CTRN income_statement (annual, 2023-01-31) — Net Interest Income: 728000.00
CTRN cash_flow (annual, 2023-01-31) — Net Investment Purchase And Sale: 0.00
CTRN cash_flow (annual, 2023-01-31) — Net Issuance Payments Of Debt: 0.00
CTRN income_statement (annual, 2023-01-31) — Net Non Operating Interest Income Expense: 728000.00
CTRN cash_flow (annual, 2023-01-31) — Net Other Financing Charges: -2228000.00
CTRN cash_flow (annual, 2023-01-31) — Net Other Investing Changes: 1370000.00
CTRN balance_sheet (annual, 2023-01-31) — Net PPE: 317301000.00
CTRN cash_flow (annual, 2023-01-31) — Net PPE Purchase And Sale: 58811000.00
CTRN cash_flow (annual, 2023-01-31) — Net Short Term Debt Issuance: 0.00
CTRN balance_sheet (annual, 2023-01-31) — Net Tangible Assets: 166444000.00
CTRN balance_sheet (annual, 2023-01-31) — Non Current Deferred Assets: 2893000.00
CTRN balance_sheet (annual, 2023-01-31) — Non Current Deferred Taxes Assets: 2893000.00
CTRN income_statement (annual, 2023-01-31) — Normalized EBITDA: 32846000.00
CTRN income_statement (annual, 2023-01-31) — Normalized Income: 9252100.27
CTRN cash_flow (annual, 2023-01-31) — Operating Cash Flow: 5754000.00
CTRN cash_flow (annual, 2023-01-31) — Operating Gains Losses: -64078000.00
CTRN income_statement (annual, 2023-01-31) — Operating Income: 11217000.00
CTRN income_statement (annual, 2023-01-31) — Operating Revenue: 795011000.00
CTRN balance_sheet (annual, 2023-01-31) — Ordinary Shares Number: 8354481.00
CTRN balance_sheet (annual, 2023-01-31) — Other Current Assets: 12977000.00
CTRN balance_sheet (annual, 2023-01-31) — Other Current Liabilities: 344000.00
CTRN income_statement (annual, 2023-01-31) — Other Income Expense: 64088000.00
CTRN cash_flow (annual, 2023-01-31) — Other Non Cash Items: 52885000.00
CTRN balance_sheet (annual, 2023-01-31) — Other Non Current Assets: 1183000.00
CTRN balance_sheet (annual, 2023-01-31) — Other Non Current Liabilities: 2322000.00
CTRN balance_sheet (annual, 2023-01-31) — Other Properties: 257195000.00
CTRN income_statement (annual, 2023-01-31) — Other Special Charges: -64088000.00
CTRN balance_sheet (annual, 2023-01-31) — Payables: 80670000.00
CTRN balance_sheet (annual, 2023-01-31) — Payables And Accrued Expenses: 96725000.00
CTRN balance_sheet (annual, 2023-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 10823000.00
CTRN income_statement (annual, 2023-01-31) — Pretax Income: 76033000.00
CTRN balance_sheet (annual, 2023-01-31) — Properties: 0.00
CTRN cash_flow (annual, 2023-01-31) — Purchase Of Investment: 0.00
CTRN cash_flow (annual, 2023-01-31) — Purchase Of PPE: -22287000.00
CTRN balance_sheet (annual, 2023-01-31) — Receivables: 615000.00
CTRN income_statement (annual, 2023-01-31) — Reconciled Cost Of Revenue: 484022000.00
CTRN income_statement (annual, 2023-01-31) — Reconciled Depreciation: 20595000.00
CTRN cash_flow (annual, 2023-01-31) — Repayment Of Debt: 0.00
CTRN cash_flow (annual, 2023-01-31) — Repurchase Of Capital Stock: -10000000.00
CTRN balance_sheet (annual, 2023-01-31) — Retained Earnings: 331050000.00
CTRN cash_flow (annual, 2023-01-31) — Sale Of Investment: 0.00
CTRN cash_flow (annual, 2023-01-31) — Sale Of PPE: 81098000.00
CTRN income_statement (annual, 2023-01-31) — Selling General And Administration: 279177000.00
CTRN balance_sheet (annual, 2023-01-31) — Share Issued: 16158494.00
CTRN cash_flow (annual, 2023-01-31) — Short Term Debt Issuance: 0.00
CTRN cash_flow (annual, 2023-01-31) — Short Term Debt Payments: 0.00
CTRN income_statement (annual, 2023-01-31) — Special Income Charges: 64088000.00
CTRN cash_flow (annual, 2023-01-31) — Stock Based Compensation: 3635000.00
CTRN balance_sheet (annual, 2023-01-31) — Stockholders Equity: 166444000.00
CTRN balance_sheet (annual, 2023-01-31) — Tangible Book Value: 166444000.00
CTRN income_statement (annual, 2023-01-31) — Tax Effect Of Unusual Items: 14448100.27
CTRN income_statement (annual, 2023-01-31) — Tax Provision: 17141000.00
CTRN income_statement (annual, 2023-01-31) — Tax Rate For Calcs: 0.23
CTRN balance_sheet (annual, 2023-01-31) — Taxes Receivable: 615000.00
CTRN balance_sheet (annual, 2023-01-31) — Total Assets: 544258000.00
CTRN balance_sheet (annual, 2023-01-31) — Total Capitalization: 166444000.00
CTRN balance_sheet (annual, 2023-01-31) — Total Debt: 267600000.00
CTRN balance_sheet (annual, 2023-01-31) — Total Equity Gross Minority Interest: 166444000.00
CTRN income_statement (annual, 2023-01-31) — Total Expenses: 783794000.00
CTRN balance_sheet (annual, 2023-01-31) — Total Liabilities Net Minority Interest: 377814000.00
CTRN balance_sheet (annual, 2023-01-31) — Total Non Current Assets: 321377000.00
CTRN balance_sheet (annual, 2023-01-31) — Total Non Current Liabilities Net Minority Interest: 217261000.00
CTRN income_statement (annual, 2023-01-31) — Total Operating Income As Reported: 75305000.00
CTRN income_statement (annual, 2023-01-31) — Total Unusual Items: 64088000.00
CTRN income_statement (annual, 2023-01-31) — Total Unusual Items Excluding Goodwill: 64088000.00
CTRN balance_sheet (annual, 2023-01-31) — Treasury Shares Number: 7804013.00
CTRN balance_sheet (annual, 2023-01-31) — Treasury Stock: 267211000.00
CTRN balance_sheet (annual, 2023-01-31) — Working Capital: 62328000.00
CTRN income_statement (annual, 2024-01-31) — +Operating Expense: 303520000.00
CTRN income_statement (annual, 2024-01-31) — +Total Revenue: 747941000.00
CTRN balance_sheet (annual, 2024-01-31) — Accounts Payable: 100366000.00
CTRN balance_sheet (annual, 2024-01-31) — Accumulated Depreciation: -276446000.00
CTRN balance_sheet (annual, 2024-01-31) — Additional Paid In Capital: 105686000.00
CTRN cash_flow (annual, 2024-01-31) — Asset Impairment Charge: 1051000.00
CTRN income_statement (annual, 2024-01-31) — Basic Average Shares: 8221000.00
CTRN income_statement (annual, 2024-01-31) — Basic EPS: -1.46
CTRN cash_flow (annual, 2024-01-31) — Beginning Cash Position: 103495000.00
CTRN balance_sheet (annual, 2024-01-31) — Buildings And Improvements: 4786000.00
CTRN cash_flow (annual, 2024-01-31) — Capital Expenditure: -14875000.00
CTRN balance_sheet (annual, 2024-01-31) — Capital Lease Obligations: 234652000.00
CTRN balance_sheet (annual, 2024-01-31) — Capital Stock: 160000.00
CTRN balance_sheet (annual, 2024-01-31) — Cash And Cash Equivalents: 79706000.00
CTRN balance_sheet (annual, 2024-01-31) — Cash Cash Equivalents And Short Term Investments: 79706000.00
CTRN cash_flow (annual, 2024-01-31) — Cash Flow From Continuing Financing Activities: -854000.00
CTRN cash_flow (annual, 2024-01-31) — Cash Flow From Continuing Investing Activities: -13358000.00
CTRN cash_flow (annual, 2024-01-31) — Cash Flow From Continuing Operating Activities: -9577000.00
CTRN cash_flow (annual, 2024-01-31) — Change In Account Payable: 17861000.00
CTRN cash_flow (annual, 2024-01-31) — Change In Accrued Expense: -62295000.00